Biotestcell 1 & 2 contained red blood cells with known phenotypes used to screen for antibodies during immunohematology serologic testing. In a notice issued on September 11, Bio-Rad Medical Diagnostics GmbH reported that the red blood cells in lot 8731011-00 contained in vial 1 (donor #100136) had been declared phenotype Fy(a+ b-), when the correct phenotype was Fy(a+ b+w).